rs9332975
From SNPedia
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(A;A) | 0 | common in clinvar |
Make rs9332975(A;G) |
Make rs9332975(G;G) |
Reference | GRCh38 38.1/142 |
Chromosome | 2 |
Position | 31525347 |
Gene | SRD5A2 |
is a | snp |
is | mentioned by |
dbSNP | rs9332975 |
dbSNP (classic) | rs9332975 |
ClinGen | rs9332975 |
ebi | rs9332975 |
HLI | rs9332975 |
Exac | rs9332975 |
Gnomad | rs9332975 |
Varsome | rs9332975 |
LitVar | rs9332975 |
Map | rs9332975 |
PheGenI | rs9332975 |
Biobank | rs9332975 |
1000 genomes | rs9332975 |
hgdp | rs9332975 |
ensembl | rs9332975 |
geneview | rs9332975 |
scholar | rs9332975 |
rs9332975 | |
pharmgkb | rs9332975 |
gwascentral | rs9332975 |
openSNP | rs9332975 |
23andMe | rs9332975 |
SNPshot | rs9332975 |
SNPdbe | rs9332975 |
MSV3d | rs9332975 |
GWAS Ctlg | rs9332975 |
GMAF | 0.1276 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
[PMID 23499746] SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists
ClinVar | |
---|---|
Risk | rs9332975(G;G) |
Alt | rs9332975(G;G) |
Reference | Rs9332975(A;A) |
Significance | Probable-non-pathogenic |
Disease | not provided 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
Variation | info |
Gene | SRD5A2 |
CLNDBN | not provided 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
Reversed | 1 |
HGVS | NC_000002.11:g.31750417T>C |
CLNSRC | ClinVar |
CLNACC | RCV000083668.1, RCV000365985.1, |